|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Sep 30, 2021
|
FY2020
12 months to Sep 30, 2020
|
FY2019
12 months to Sep 30, 2019
|
FY2017
12 months to Sep 30, 2017
|
|
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net income (loss) | |||||
| Net loss from discontinued operations | |||||
| Loss from continuing operations | |||||
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | |||||
| Depreciation | |||||
| Amortization | |||||
| Non cash amortization of right-of-use asset and liability | |||||
| Provision for excess and obsolete inventories | |||||
| Charge for lower of cost or net realizable value inventories | |||||
| Impairment of right-of-use asset | |||||
| Impairment of intangibles including goodwill | |||||
| Gain on disposal of property and equipment | |||||
| Deferred income tax provision (benefit) | |||||
| Share based compensation expense | |||||
| Gain from equity method investment | |||||
| Gain on extinguishment of debt | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Unbilled revenue | |||||
| Income tax refund receivable\payable | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Deferred revenue | |||||
| Net cash used in operating activities – continuing operations | |||||
| Net cash provided by operating activities – discontinued operations | |||||
| Deferred revenue | |||||
| Net cash provided by (used in) operating activities | |||||
| Investing Activities: | |||||
| Acquisition of net operating assets | |||||
| Proceeds from sale of business | |||||
| Loan repayments from equity method investee | |||||
| Proceeds from promissory note receivable | |||||
| Purchases of property and equipment | |||||
| Disposals of property and equipment | |||||
| Net cash provided by (used in) investing activities – continuing operations | |||||
| Net cash provided by investing activities – discontinued operations | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing Activities: | |||||
| Proceeds from note payable | |||||
| Proceeds from share issuances and exercise of stock options | |||||
| Guaranteed payments for acquisition of business | |||||
| Change in bank line of credit | |||||
| Payments on financing lease obligations | |||||
| Payments on notes payable | |||||
| Net cash provided by (used in) financing activities – continuing operations | |||||
| Net cash used in financing activities – discontinued operations | |||||
| Proceeds from sale of common stock | |||||
| Proceeds from stock options exercised | |||||
| Net cash (used in) provided by financing activities | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash paid for interest | |||||
| Promissory note from disposition of business | |||||
| Cash, cash equivalents and restricted cash at beginning of year | |||||
| Cash, cash equivalents and restricted cash at end of year | |||||
Loading...